Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Schizophr Res. 2011 Jun 1;130(1-3):164–169. doi: 10.1016/j.schres.2011.05.007

Table 3.

Results of regression analyses of the relation of movement abnormality at initial assessment with global social and role functioning at one year follow-up assessment

Predictor     Block I
(GSF/GRF Time 1)
     Block II
(Psychotripic Medicationa)
   Block III
R2 df F p β R2
change
df F p β R2
change
df F p β

Global Social Functioning
 Baseline Movements .25 (1,38) 12.73 .01** .50 .03 (3,35) .51 .67 NS .10 (1,34) 5.75 .01** −.33
Global Role Functioning
 Baseline Movements .22 (1,38) 10.60 .01** .47 .03 (3,35) .45 .71 NS .05 (1,34) 4.03 .07 −.23
**

p<0.01;

p< 0.10 (Statistical Trend).

a

Psychotropic medication class included stimulants, antidepressant, and antipsychotics.